What's New ? - 2019

What's New ? - 2019

Ceva to acquire IDT animal health business

1 June, 2019

Ceva Santé Animale (“Ceva”) and IDT Biologika GmbH (“IDT”) have reached a provisional agreement for Ceva to acquire IDT’s veterinary biopharmaceutical portfolio and R&D activities. The deal is subject to approval by the Germany's Federal Cartel Office (Bundeskartellamt) and is expected to be concluded by July 1 2019.
IDT Biologika is an innovative, privately held company with nearly 100 years of experience in researching, developing, manufacturing and marketing products for the global protection of human and animal health.